ENTA Enanta Pharmaceuticals Forecast, Technical & Fundamental Analysis
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications... Show more
ENTA is expected to report earnings to fall 3.78% to -64 cents per share on November 23
Q3'26
Est.
$-0.64
Q2'26
Missed
by $0.17
Q1'26
Beat
by $0.12
Q4'25
Beat
by $0.39
Q3'25
Beat
by $0.14
The last earnings report on August 10 showed earnings per share of -67 cents, missing the estimate of -50 cents. With 269.74K shares outstanding, the current market capitalization sits at 410.67M.
A.I. Advisor
published General Information
General Information
a developer of drugs and other pharmaceuticals products
A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ORKA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ORKA could also see price increases.
ENTA in upward trend: 10-day moving average crossed above 50-day moving average on August 10, 2026
The 10-day moving average for ENTA crossed bullishly above the 50-day moving average on August 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 24, 2026. You may want to consider a long position or call options on ENTA as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ENTA just turned positive on August 18, 2026. Looking at past instances where ENTA's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
ENTA moved above its 50-day moving average on August 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTA advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 52 cases where ENTA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 50-day moving average for ENTA moved below the 200-day moving average on July 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ENTA broke above its upper Bollinger Band on August 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ENTA entered a downward trend on August 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ENTA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.063) is normal, around the industry mean (20.202). P/E Ratio (0.000) is within average values for comparable stocks, (22.945). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.854). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.848) is also within normal values, averaging (443.091).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
